| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.077 | 0.06 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.06 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.06 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.06 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.06 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.084 | 0.06 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |